Skip to main content
BrightFocus Foundation
  • BrightFocus.org
  • Molecular Neurodegeneration Journal
  • Apply for a Grant
  • Programs
    • Alzheimer's Disease Research
      • ADR Request For Proposals
      • For Current Awardees
      • ADR Alumni Network
      • Recently Funded
    • Macular Degeneration Research
      • MDR Request For Proposals
      • For Current Awardees
      • MDR Alumni Network
      • Recently Funded
    • National Glaucoma Research
      • NGR Request For Proposals
      • For Current Awardees
      • NGR Alumni Network
      • Recently Funded
  • Grant Search
  • Recently Funded
  • Alumni Network
  • Events and Conferences
BrightFocus Foundation
  • Programs
    • Alzheimer's Disease Research
      • ADR Request For Proposals
      • For Current Awardees
      • ADR Alumni Network
      • Recently Funded
    • Macular Degeneration Research
      • MDR Request For Proposals
      • For Current Awardees
      • MDR Alumni Network
      • Recently Funded
    • National Glaucoma Research
      • NGR Request For Proposals
      • For Current Awardees
      • NGR Alumni Network
      • Recently Funded
  • Grant Search
  • Recently Funded
  • Alumni Network
  • Events and Conferences
  • BrightFocus.org
  • Molecular Neurodegeneration Journal
  • Apply for a Grant

Alzheimer's Disease Research

Since 1985, the Alzheimer's Disease Research (ADR) program has awarded nearly $170 million to support promising research in fields ranging from molecular biology to genetics to epidemiology. ADR is currently supporting 167 outstanding biomedical researcher projects.

Dr. David Irwin looking into a microscope,
Request for Proposal

Highlights

A Precivity scientist working in the lab.

BrightFocus an Early Supporter of “Game Changing” Alzheimer’s Disease Blood Test

An illustration of DNA molecules.

New Genes and Variants Discovered to Contribute to Alzheimer’s Risk

Fats accumulating in brain immune cells surrounded by amyloid plaques.

New Evidence on How TREM2 Gene and Mutations Impact Alzheimer’s

An illustration of neurons.

Alzheimer's Fast Track 2022

Logos of Astrocyte,  MTEC, and BrightFocus Foundation.

Astrocyte Pharmaceuticals Awarded Major Grant to Further Develop Promising Treatment for Brain Injury

Dr. Patrick Kehoe speaking at the podium.

BrightFocus Alzheimer’s Researcher Offers Insights into COVID-19

Apply to Current RFP
For Current Awardees
Scientist Profiles
List of Grants

Yearbooks

2021 ADR Grants Yearbook
2020 ADR Grants Yearbook
2019 ADR Grants Yearbook
2018 ADR Grants Yearbook
2017 ADR Grants Yearbook
2016 ADR Grants Yearbook

Categories

Amyloid Beta
APOE and Lipids
Biomarkers
Cells & Circuits
Drugs & Treatments
Genomics
Immunity & Inflammation
Neurovascular
Tau
Tools & Resources
Translational & Clinical

Grants Notification

Site Footer

BrightFocus Foundation

BrightFocus Foundation

22512 Gateway Center Drive

Clarksburg, MD 20871

 

Phone: 1.800.437.2423

Fax: 301.258.9454

Email: researchgrants@brightfocus.org

  • Alzheimer's Disease Research
  • Macular Degeneration Research
  • National Glaucoma Research
  • Apply for a Grant
  • Recently Funded
  • Grant Search
  • Alumni Network
  • Contact Us
  • Molecular Neurodegeneration Journal
  • Events & Conferences
  • Frequently Asked Questions
  • Intellectual Property Policy

BrightFocus is a tax-exempt nonprofit organization under section 501(c)(3) of the Internal Revenue Code of the United States.

Copyright 2000 - 2020 BrightFocus Foundation. All rights reserved.

The information provided here is a public service of the BrightFocus Foundation and should not in any way substitute for personalized advice of a qualified healthcare professional; it is not intended to constitute medical advice. Please consult your physician for personalized medical advice. BrightFocus Foundation does not endorse any medical product, therapy, or resources mentioned or listed in this article. All medications and supplements should only be taken under medical supervision. Also, although we make every effort to keep the medical information on our website updated, we cannot guarantee that the posted information reflects the most up-to-date research.

These articles do not imply an endorsement of BrightFocus by the author or their institution, nor do they imply an endorsement of the institution or author by BrightFocus.

Some of the content may be adapted from other sources, which will be clearly identified within the article.

  • Legal Information
  • Do Not Sell My Info
  • Accountability
  • For Financial Advisors
  • Privacy Information